Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect early-stage metabolic-associated steatotic liver disease (MASLD) by using electronic health records.
American Association for the Study of Liver Disease sNov 18 2024 Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect early-stage metabolic-associated steatotic liver disease by using electronic health records. The study was scheduled for presentation today at The Liver Meeting, hosted by the American Association for the Study of Liver Disease s.
Ariana Stuart MD, resident at University of Washington Internal Medicine Residency Program and lead author of the study "People should not interpret our findings as a lack of primary care training or management," Stuart said. "Instead, our study shows how AI can complement physician workflow to address the limitations of traditional clinical practice."
Liver Disease Artificial Intelligence Hepatology Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Persistent activation of DNA damage response in the liver after MASLD reversalMetabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced form, metabolic dysfunction-associated steatohepatitis, have emerged as the most prevalent liver diseases worldwide.
Read more »
Advanced fibrosis linked to liver complications in biopsy-proven MASLDData regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited.
Read more »
Exploring mouse models for studying liver fibrosis regressionLiver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be caused by a variety of factors, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol abuse, and viral hepatitis.
Read more »
Understanding metabolic alterations and immune dysfunction in acute-on-chronic liver failureAcute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function in patients with pre-existing chronic liver disease.
Read more »
The new faces of cancer: Tragedy of young, fit women in their 20s and 30s being struck down by...Glamorous TikTok star Rachel Yaffe speaks about rare stage four liver cancer before her recent death.
Read more »
NHS share liver cancer red flag signs as UK cases set to rise by 2025This illness is now the fastest rising cause of cancer deaths in the UK, but only 33% to 50% of cases are diagnosed at an early stage.
Read more »